Actinogen Medical Stock

Detail Data
Volume (24h): 2,322,883 shares
P/E Ratio: /
Forward P/E: -1.90
EPS: /
Forward EPS: -0.01 AUD
Number of Shares: 3,177,149,952 shares
Market Capitalization: 60,365,848.00 AUD

Dividend

Dividend Value
Dividend Amount According to our data, the company Actinogen Medical does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for Actinogen Medical stock. The current number of analysts covering this company is No analyst coverage. The highest target price is / while the lowest target price is / The median target valuation set by analysts is / These forecasts and recommendations provide insight into how analysts view the future stock performance of Actinogen Medical.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Actinogen Medical stock is: none
Number of Analysts: Actinogen Medical is not covered by analysts.
Highest Target Price: /
Lowest Target Price: /
Median Target Price: /

Fundamental Indicators

Indicator Data
Total Revenue: 9,022,474.00 AUD
Net Income: -9,656,602.00 AUD
Price-to-Book (P/B): 2.37
PEG Ratio: /
Exchange: ASX
Industry: Biotechnology
Sector: Healthcare
Number of Employees:
Country: Australia

Where to Buy Actinogen Medical Stock?

You can purchase Actinogen Medical stock on the ASX under the ticker symbol: ACW.AX. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Actinogen Medical Stock

Indicator Value
Company Revenue: 9,022,474.00 AUD
EBITDA: -9,638,857.00 AUD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -
Book Value Per Share: 0.01 AUD
Total Cash: 22,865,980.00 AUD
Total Cash per Share: 0.01 AUD
Total Debt: 289,645.00 AUD
Debt to Equity Ratio: 0.01
Quick Ratio 18.73
Current Ratio 18.76
Free Cash Flow -5,306,036.00 AUD
Operating Cash Flow -8,720,297.00 AUD
Gross Margins 100.00 %
EBITDA Margins -106.83 %
Operating Margins -110.44 %
Profit Margins -107.03 %
Return on Assets -31.5 %
Return on Equity -53.7 %
Earnings Growth (1 year) -
Revenue Growth (1 year) -
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 60,365,848.00 AUD
Enterprise Value 36,947,128.00 AUD
EV/Revenue 4.095
EV/EBITDA -3.833
Float Shares 2,563,424,888 shares
Shares Outstanding 3,177,149,952 shares
Held Percent Insiders 0.16 %
Held Percent Institutions 0.68 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 1.04
Short Percentage of Float -
Implied Shares Outstanding 3,177,149,952

Frequently Asked Questions (FAQ)

According to our data, the company Actinogen Medical does not pay dividends yet, even in 2025.

Actinogen Medical shares are traded on the ASX stock exchange under the ticker: ACW.AX. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

No prediction or recommendation from analysts has been issued for Actinogen Medical shares yet.

The total number of Actinogen Medical shares on the exchange is 3,177,149,952.00 shares, which at the current market capitalization gives the company a total valuation of 60,365,848.00 AUD.